Filing Details

Accession Number:
0001062993-25-005651
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-17 20:09:34
Reporting Period:
2024-06-07
Filing Date:
2025-03-17
Accepted Time:
2025-03-17 20:09:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1521036 Lantheus Holdings Inc. LNTH In Vitro & In Vivo Diagnostic Substances (2835) 352318913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1610676 Anne Mary Heino C/O Lantheus Holdings, Inc.
201 Burlington Road, South Bldg
Bedford MA 01730
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-06-07 1 $81.26 37,719 No 4 S Indirect By Grantor Retained Annuity Trust
Common Stock Disposition 2025-03-13 2 $100.13 8,618 No 4 S Indirect By Grantor Retained Annuity Trust
Common Stock Disposition 2025-03-13 8,618 $0.00 0 No 4 G Indirect By Grantor Retained Annuity Trust
Common Stock Acquisiton 2025-03-13 8,618 $0.00 8,618 No 4 G Indirect By Heino Irrevocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Grantor Retained Annuity Trust
No 4 S Indirect By Grantor Retained Annuity Trust
No 4 G Indirect By Grantor Retained Annuity Trust
No 4 G Indirect By Heino Irrevocable Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 440,399 Direct
Common Stock 121,514 Indirect By The Mary Anne Fennell Heino Revocable Trust - 2018
Footnotes
  1. Balance reflects 121,514 shares transferred from a Grantor Retained Annuity Trust ("GRAT") to the The Mary Anne Fennell Heino Revocable Trust - 2018 on March 13, 2025. This transfer is exempt from Section 16 pursuant to Rule 16a-13.
  2. Balance reflects 121,514 shares transferred from a GRAT to the The Mary Anne Fennell Heino Revocable Trust - 2018 on March 13, 2025. This transfer is exempt from Section 16 pursuant to Rule 16a-13.